BIRC5 and breast cancer: In a recent study, Chen et al. proposed redox-sensitive oligopeptide liposomes for co-delivery of paclitaxel and anti-survivin siRNA for the synergistic treatment and efficient anti-metastasis strategy against breast cancer (234).